BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24327761)

  • 1. Interferon-γ resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis.
    Londhe P; Davie JK
    Sci Signal; 2013 Dec; 6(305):ra107. PubMed ID: 24327761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma interferon modulates myogenesis through the major histocompatibility complex class II transactivator, CIITA.
    Londhe P; Davie JK
    Mol Cell Biol; 2011 Jul; 31(14):2854-66. PubMed ID: 21576360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JARID2 and the PRC2 complex regulate skeletal muscle differentiation through regulation of canonical Wnt signaling.
    Adhikari A; Davie J
    Epigenetics Chromatin; 2018 Aug; 11(1):46. PubMed ID: 30119689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
    Walters ZS; Villarejo-Balcells B; Olmos D; Buist TW; Missiaglia E; Allen R; Al-Lazikani B; Garrett MD; Blagg J; Shipley J
    Oncogene; 2014 Feb; 33(9):1148-57. PubMed ID: 23435416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
    Truax AD; Thakkar M; Greer SF
    PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.
    Ghorpade DS; Holla S; Sinha AY; Alagesan SK; Balaji KN
    J Biol Chem; 2013 Jul; 288(28):20592-606. PubMed ID: 23733190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JARID2 and the PRC2 complex regulate the cell cycle in skeletal muscle.
    Adhikari A; Mainali P; Davie JK
    J Biol Chem; 2019 Dec; 294(51):19451-19464. PubMed ID: 31578284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin.
    Son J; Shen SS; Margueron R; Reinberg D
    Genes Dev; 2013 Dec; 27(24):2663-77. PubMed ID: 24352422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
    Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
    Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycomb Repressive Complex 2 Confers BRG1 Dependency on the CIITA Locus.
    Abou El Hassan M; Yu T; Song L; Bremner R
    J Immunol; 2015 May; 194(10):5007-13. PubMed ID: 25862816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ppp1r1b-lncRNA inhibits PRC2 at myogenic regulatory genes to promote cardiac and skeletal muscle development in mouse and human.
    Kang X; Zhao Y; Van Arsdell G; Nelson SF; Touma M
    RNA; 2020 Apr; 26(4):481-491. PubMed ID: 31953255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.
    Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R
    Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma.
    Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
    J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
    Xu Y; Wang L; Butticè G; Sengupta PK; Smith BD
    J Biol Chem; 2004 Oct; 279(40):41319-32. PubMed ID: 15247294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jarid2 and PRC2, partners in regulating gene expression.
    Li G; Margueron R; Ku M; Chambon P; Bernstein BE; Reinberg D
    Genes Dev; 2010 Feb; 24(4):368-80. PubMed ID: 20123894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis.
    Seenundun S; Rampalli S; Liu QC; Aziz A; Palii C; Hong S; Blais A; Brand M; Ge K; Dilworth FJ
    EMBO J; 2010 Apr; 29(8):1401-11. PubMed ID: 20300060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA
    Jin JJ; Lv W; Xia P; Xu ZY; Zheng AD; Wang XJ; Wang SS; Zeng R; Luo HM; Li GL; Zuo B
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9802-E9811. PubMed ID: 30279181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin.
    Kaneko S; Bonasio R; Saldaña-Meyer R; Yoshida T; Son J; Nishino K; Umezawa A; Reinberg D
    Mol Cell; 2014 Jan; 53(2):290-300. PubMed ID: 24374312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.